/
CMRA
$0.00+$0.00 (+9,900.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
50% from low
Exchange
OTC Link
CS
Price (6 mo)
Loading chart…
Change$-8.85
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Revenue | $442.9K | $319.8K | $633.1K |
| Cost of revenue | $104.4K | $161.0K | $210.4K |
| Gross profit | $338.5K | $158.8K | $422.7K |
| Gross margin | 76.4% | 49.7% | 66.8% |
| R&D | $1.3M | $1.8M | $1.7M |
| Operating income | −$2.1M | −$5.5M | −$12.0M |
| EBITDA | −$2.0M | −$5.4M | −$17.9M |
| Net income | −$2.1M | −$5.5M | −$18.0M |
| Net margin | -479.9% | -1704.6% | -2843.8% |
| EPS (diluted) | -0.11 | -0.29 | -1.76 |
Annual figures · source: Financial Modeling Prep
Peer comparison
COMERA LIFE SCIENCES HLDG
COMERA LIFE SCIENCES HLDG
Held by traders on TradeandTell
No one on the platform currently holds CMRA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CMRA as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2003-05-21 | 1-for-800reverse |
Recent trades on TradeandTell
No one on the platform has traded CMRA yet.
